Carey Olsen and Alter Domus advise Gyrus Capital on €310 million fund
Carey Olsen and Alter Domus have advised healthcare and sustainability investment firm Gyrus Capital S.A ("Gyrus") on the final close of its €310 million Gyrus Capital Fund II ("Fund II"), exceeding the €215 million raised for Gyrus Fund I (2021).
Fund II consists of the Principal Fund and an open-ended co-investment vehicle, allowing Gyrus to make larger investments. With its close, the total number of funds raised since the firm was established in November 2018 exceeds €750 million.
Fund II will be a continuation of Fund I, generating returns from investments into businesses operating in the healthcare and sustainability sectors. Asset managers, public and private pension funds, insurance companies and family offices across Europe, North America, the Middle East and Asia have invested in Fund II. The Fund has already completed its first investment, LRE Medical, a leading provider of point of care diagnostic and life sciences devices which employs more than 250 people across two sites in Germany.
The Carey Olsen Guernsey corporate team advising Gyrus comprised David Crosland, senior associate James Cooke and associates Claire Cooke and Bhavik Mehta.
Alter Domus Guernsey has, alongside Carey Olsen, supported Gyrus since their Fund I launch, providing specialist fund administration solutions from their local office. The fund services team supporting Gyrus’ Fund II closings included director Tom Amy, associate director Katie Le Gallez, manager James Arrol and senior officer Dan Guilbert.
Based in Geneva, Gyrus is dedicated to transformational investments in the healthcare and sustainability sectors. The firm invests in businesses that address the structural needs of society and the environment, positioned for long-term, sustainable growth. It focuses on complex transactions such as corporate carve-outs and entrepreneur successions in the €50 to €500 million range.
